NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/03/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Primeiro uso
Primeiro uso no comércio
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of designed letters "SYN-NAT".
Titulares
Representantes
Timothy T. Wang NI, WANG & MASSAND, PLLC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Tonics of medicines, namely, medicinal tea; Medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; Medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Medicinal drinks; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Chemico-pharmaceutical preparations for tumor-suppression and antiviral treatment; Troches, namely, tablets for use in tumor-suppression, as antivirals and for the treatment of chronic gastrointestinal disease; Tinctura in the nature of medicinal herb extracts; Herbs for medicinal purposes; Nutritional supplements; dietetic foods adapted for medical use, namely, dietetic drinks, dietetic crackers, dietetic sugar for medical use, dietetic sugar substitutes for medical use; Dietary and nutritional supplements; Dietary food supplements; Dietary supplemental drinks; Dietary supplements; Dietetic beverages adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic foods and beverages adapted for medical use; Nutraceuticals for use as a dietary supplement; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; Sanitizing preparations for commercial use
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/03/2025
REGISTERED-PRINCIPAL REGISTER
11/03/2025
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
15/02/2025
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15/02/2025
STATEMENT OF USE PROCESSING COMPLETE
14/02/2025
CASE ASSIGNED TO INTENT TO USE PARALEGAL
14/02/2025
USE AMENDMENT FILED
03/12/2024
TEAS STATEMENT OF USE RECEIVED
03/12/2024
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/06/2024
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/04/2024
PUBLISHED FOR OPPOSITION
02/04/2024
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/03/2024
APPROVED FOR PUB - PRINCIPAL REGISTER
29/02/2024
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
29/08/2023
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/03/2023
ASSIGNED TO EXAMINER
17/01/2023
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/09/2022
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/03/2022
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
28/08/2021
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
17/02/2021
LETTER OF SUSPENSION E-MAILED
17/02/2021
SUSPENSION LETTER WRITTEN
17/02/2021
TEAS/EMAIL CORRESPONDENCE ENTERED
16/02/2021
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/02/2021
TEAS/EMAIL CORRESPONDENCE ENTERED
26/01/2021
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/01/2021
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/01/2021
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/08/2020
NON-FINAL ACTION E-MAILED
16/08/2020
NON-FINAL ACTION WRITTEN
16/08/2020
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
15/08/2020
LETTER OF SUSPENSION E-MAILED
15/08/2020
SUSPENSION LETTER WRITTEN
15/08/2020
ASSIGNED TO EXAMINER
08/08/2020
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/05/2020
NEW APPLICATION ENTERED
15/05/2020
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.